Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.46
Delayed Data
As of Sep 23
 +0.01 / +0.29%
Today’s Change
3.18
Today|||52-Week Range
34.40
-79.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
AssetsCash154.3M155.4M183.0M243.4M
 
 
 
 
 
Short Term Investment Cash82.7M1.1M-87.5M10.2M
 
 
 
 
 
Cash & Short Term Investments233.4M214.0M242.1M264.4M
 
 
 
 
 
 
ReceivablesReceivables4.6M6.8M2.8M2.9M
 
 
 
 
 
 
InventoriesInventories11.1M10.8M15.0M11.5M
 
 
 
 
 
 
Current AssetsOther Current Assets2.8M2.3M2.6M4.0M
 
 
 
 
 
Current Assets251.8M233.9M262.4M282.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.1M3.5M3.7M3.8M
 
 
 
 
 
Depreciation-2.2M-2.2M-2.3M-2.4M
 
 
 
 
 
Other Assets1.4M1.3M60.9M61.2M
 
 
 
 
 
Total Assets254.3M236.6M375.0M345.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.9M6.5M4.6M4.1M
 
 
 
 
 
Accrued Expenses17.7M10.7M14.1M17.7M
 
 
 
 
 
Other Current Liabilities27.7M20.3M23.7M27.3M
 
 
 
 
 
Other Liabilities35.4M32.2M30.4M34.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt87.0M88.1M209.0M206.4M
 
 
 
 
 
Deferred Taxes-547.0K0.000.000.00
 
 
Other Liabilities206.0K150.0K41.1M33.1M
 
 
 
 
 
Total Liabilities208.1M203.2M360.7M352.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.003.3M3.3M
 
 
 
Common Equity46.2M33.4M10.9M-10.0M
 
 
 
 
 
Total Shareholder Equity46.2M33.4M14.2M-6.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding14.5M14.6M14.6M14.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.